Rhododendron groenlandicum(Labrador tea), an antidiabetic plant from the traditional pharmacopoeia of the Canadian Eastern James Bay Cree, improves renal integrity in the diet-induced obese mouse model
- 26 February 2016
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 54 (10) , 1998-2006
Abstract
Content Our team has identified Labrador tea [Rhododendron groenlandicum L. (Ericaceae)] as a potential antidiabetic plant from the traditional pharmacopoeia of the Eastern James Bay Cree. In a previous in vivo study, the plant extract was tested in a high-fat diet (HFD)-induced obese model using C57BL/6 mice and it improved glycaemia, insulinaemia and glucose tolerance. Objective In the present study, we assessed the plant’s potential renoprotective effects. Materials and methods Rhododendron groenlandicum was administered at 250 mg/kg/d to mice fed HFD for 8 weeks to induce obesity and mild diabetes. Histological (periodic acid–Schiff (PAS), Masson and Oil Red O staining), immunohistochemical (IHC) and biochemical parameters were assessed to evaluate the renoprotective potential of R. groenlandicum treatment for an additional 8 weeks. Results Microalbuminuria and renal fibrosis were developed in HFD-fed mice. Meanwhile, there was a tendency for R. groenlandicum to improve microalbuminuria, with the values of albumin-creatinine ratio (ACR) reducing from 0.69 to 0.53. Renal fibrosis value was originally 4.85 arbitrary units (AU) in HFD-fed mice, dropped to 3.27 AU after receiving R. groenlandicum treatment. Rhododendron groenlandicum reduced renal steatosis by nearly one-half, whereas the expression of Bcl-2-modifying factor (BMF) diminished from 13.96 AU to 9.43 AU. Discussion and conclusions Taken altogether, the results suggest that R. groenlandicum treatment can improve renal function impaired by HFD.Keywords
This publication has 34 references indexed in Scilit:
- Mechanisms of Action of Indigenous Antidiabetic Plants from the Boreal Forest of Northeastern CanadaAdvances in Endocrinology, 2014
- Biomarkers in diabetic nephropathy: Present and futureWorld Journal of Diabetes, 2014
- Mechanisms of Diabetic ComplicationsPhysiological Reviews, 2013
- Role of Sphingolipid Mediator Ceramide in Obesity and Renal Injury in Mice Fed a High-Fat DietThe Journal of Pharmacology and Experimental Therapeutics, 2010
- APPL1 Potentiates Insulin-Mediated Inhibition of Hepatic Glucose Production and Alleviates Diabetes via Akt Activation in MiceCell Metabolism, 2009
- Attenuation of Interstitial Fibrosis and Tubular Apoptosis in db/db Transgenic Mice Overexpressing Catalase in Renal Proximal Tubular CellsDiabetes, 2008
- Kidneys sans glomeruliAmerican Journal of Physiology-Renal Physiology, 2004
- The Early Natural History of Nephropathy in Type 1 DiabetesDiabetes, 2002
- Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration.Diabetes Care, 1999
- Epidemiology of obesity in relationship to some chronic medical conditions among Inuit and Cree Indian populations in New Quebec, CanadaDiabetes Research and Clinical Practice, 1990